BIORIGEN USA, Inc. Is to Enter $4-$6 Billion Market of "Bone Repair by Tissue Engineering"

BIORIGEN USA, Inc. Is to Enter $4-$6 Billion Market of "Bone Repair by Tissue Engineering"
New Life Scientific, Inc. (OTCBB: NWLS) todayannounced that it has established BIORIGEN USA, Inc., a joint venturecompany with Biorigen Srl, (Genoa, Italy), a Biotech Company and CentroBiotecnologie Avanzate (Genoa, Italy) to pursue development of a series ofresearch projects, the first one being the project of 'Bone Repair byTissue Engineering' that is using novel biotechnology. Under the

Premium Health Search Engine